Anacetrapib clinical trials

REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification

The REVEAL trial looked at whether a drug called anacetrapib could help people with existing heart and circulatory problems. It aimed to see if this drug, when added to usual statin treatment, could lower their risk of serious heart events like heart attacks. The study has now finished.